Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Nov 8, 2021 · 10-Q · 39 days after period end · 0001564590-21-055073
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$36.66M | -$34.11M | -$68.11M | -$290.00K |
| EPS Diluted | -$0.98 | -$1.02 | -$9.30 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 8, 2021 · 39 d after period end
